Back to search

Article

Cross-reactivity reduced dengue virus serotype 2 vaccine does not confer cross-protection against other serotypes of dengue viruses

2018-11-27

Abstract excerpt

The four serotypes of dengue virus (DENV) cause the most important rapidly emerging arthropod-borne disease globally. The humoral immune response to DENV infection is predominantly directed against the immunodominant cross-reactive weakly neutralizing epitopes located in the highly conserved fusion peptide of ectodomain II of envelope (E) protein (EDII FP ). Antibodies recognizing EDII FP have been shown to asso...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0d2ffef1-4468-581a-bc93-015032d408b3
DOI
10.1101/480210
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Cross-reactivity reduced dengue virus serotype 2 vaccine does not confer cross-protection against other serotypes of dengue virusesDOI 10.1101/480210
Select a neighboring publication to make it the new centre.